✦ LIBER ✦

Initiating levodopa therapy for Parkinson's disease

✍ Scribed by Olanow, C. Warren; Kieburtz, Karl; Stocchi, Fabrizio

Book ID: 125928632
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 88 KB
Volume: 29
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.25805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Levodopa

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

Initiating therapy in Parkinson's diseas

Initiating therapy in Parkinson's disease

✍ William Weiner; Eric Ahlskog; Stewart Factor; Oksana Suchowersky; Stephen Reich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Initiation of symptomatic therapy in Par

Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa

✍ Nirit Lev; Ruth Djaldetti; Eldad Melamed 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

When Should Levodopa Therapy be Initiate

When Should Levodopa Therapy be Initiated in Patients with Parkinson’s Disease?

✍ Halkias, Irene A C; Haq, Ihtsham; Huang, Zhigao; Fernandez, Hubert H 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 145 KB

Optimising levodopa therapy for the mana

Optimising levodopa therapy for the management of Parkinson’s disease

✍ Fabrizio Stocchi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 224 KB

Levodopa therapy for Parkinson's disease

Levodopa therapy for Parkinson's disease: Challenges and future prospects

✍ C. Warren Olanow; Andrew Lees; Jose Obeso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB